ALX Oncology Holdings Inc at Jefferies Healthcare Conference (Virtual) Transcript
Well, welcome, everyone, and thank you for joining us at another great session at the 2021 Jefferies Global Healthcare Conference. Really happy to have here with us on this fireside chat the President and CEO of ALX Oncology, Jaume Pons; and also with us, the Chief Medical Officer, Sophia Randolph. Thank you for joining us today.
We were briefly just chatting, of course, about so many things going on. I know Sophia is quite busy with so many trials getting up and running. But I would just love to just start off first with a bit of a high-level question that I think is on the minds of many investors, maybe to Jaume, is trying to sort of parse out the CD47 landscape because there has been a lot of different companies sort of popping up. And I would just love to sort of briefly hear about why you think ALX is differentiated from some of those others that we're hearing about. That would be a good -- great place to start off.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |